Søgning

Søgning på udtrykket 'cmv' giver 22 resultater

Dokumenter [2] Nyt fra tidsskrifterne [+20]

Dokumenter [2]

Retningslinjer for screening og profylakse før behandling med biologiske lægemidler (2023)

…r (BMSL) til patienter i forhold til risiko for tuberkulose (TB), Humant Papillom Virus (HPV), Hepatitis B og C (HBV og HCV), Varicella Zoster Virus (VZV), Herpes Simplex Virus (HSV), Cytomegalovirus (CMV), Epstein Barr Virus (EBV) og Humant Immundefekt Virus (HIV) og øvrige infektioner. Vejledningen er udarbejdet af repræsentanter fra Dansk Selskab for Gastroenterologi og Hepatologi (DSGH), Dansk Reumatologisk Selskab (DRS), Dansk Dermatologisk Selskab (DDS) og Dansk Selskab for Infektionsmedicin (DSI).

DSI årsmøde program (2008)

Bl.a. om Q-feber, biomarkører og CMV

Nyt fra tidsskrifterne [+20]

Der er mere end 20 resultater, måske du vil se flere resultater her?

Possible CMV transmission via intrauterine insemination: case report

BMC Infectious Diseases

21.02.2025

. Abstract. . Background. Maternal cytomegalovirus (CMV) infection at conception can cause congenital CMV (cCMV) infection and substantial morbidity. Although CMV screening is mandated for sperm donors, the risk of acquiring CMV from donor sperm is unknown. Experience with HIV may lead clinicians to expect that standard sperm-washing reduces CMV transmission risk for procedures including intrauterine insemination.

Impact of Donor CMV‐Seropostive Grafts on Prognosis of Liver Transplantation for Hepatocellular Carcinoma

Journal of Medical Virology

7.01.2025

Journal of Medical Virology, Volume 97, Issue 1, January 2025.

Prophylactic vs preemptive strategy for the prevention of CMV disease in solid organ transplant recipients: systematic review and meta-analysis of randomized controlled trials

Infection

4.12.2024

. Abstract. . Purpose. Cytomegalovirus (CMV) is associated with significant morbidity and mortality among solid organ transplant (SOT) recipients. Strategies for CMV prevention include universal prophylaxis or preemptive approach. We aimed to evaluate the optimal approach. . . . Methods.

Immune responses drive chorioretinitis and retinal pathology after neonatal CMV infection

Science Advances

21.11.2024

Science Advances, Volume 10, Issue 47, November 2024.

Identifying Gaps in Congenital CMV Detection—Implications for the Recent European Consensus Guidelines on Congenital CMV Infection

Journal of Medical Virology

15.11.2024

Journal of Medical Virology, Volume 96, Issue 11, November 2024.

Prognostic significance of plasma cytomegalovirus (CMV) DNA load in immunocompetent patients with CMV pneumonia: A retrospective cohort study

Journal of Medical Virology

22.10.2024

Journal of Medical Virology, Volume 96, Issue 10, October 2024.

Refractory anti-viral resistant CMV retinitis in an immunological non responder person living with HIV

International Journal of Infectious Diseases

1.09.2024

CMV disease, and particularly CMV retinitis, is a frequent and potentially sight-threatening complication in patients living with HIV with CD4+ T lymphocyte count below 100 cells/mm3. The advent of potent HAART has resulted in rapid immune reconstitution for most patients, making CMV infection or disease less problematic in this population.

Clinical manifestations and immune markers of non-HIV-related CMV retinitis

BMC Infectious Diseases

7.08.2024

. Abstract. . Background. Since the HIV epidemic in the 1980s, CMV retinitis has been mainly reported in this context. CMV retinitis in persons living with HIV is usually observed when CD4 + cells are below 50 cells/mm3. This study aims to describe the immune markers of non-HIV-related CMV retinitis as well as to describe its clinical manifestations and outcomes. . . .

Consensus Definitions of Cytomegalovirus (CMV) Infection and Disease in Transplant Patients Including Resistant and Refractory CMV for Use in Clinical Trials: 2024 Update From the Transplant Associated Virus Infections Forum

Clinical Infectious Diseases

25.07.2024

Abstract . Cytomegalovirus (CMV) infection and disease are important causes of morbidity and mortality in transplant recipients. For the purpose of developing consistent reporting of CMV outcomes in clinical trials, definitions of CMV infection and disease were developed and most recently published in 2017. Since then, there have been major developments, including registration of new antiviral agents.

TTV and CMV viral load dynamics: Which emerges first during immunosuppression?

Journal of Medical Virology

18.07.2024

Journal of Medical Virology, Volume 96, Issue 7, July 2024.

Investigating the role of cytomegalovirus as a cause of stillbirths and child deaths in low and middle-income countries through postmortem minimally invasive tissue sampling

Clinical Infectious Diseases

10.03.2025

Abstract . Background . There is paucity of information on the role of cytomegalovirus (CMV) infection as a cause of stillbirths or childhood deaths in low-and middle-income countries (LMICs). We investigated attribution of CMV-disease in the causal pathway to stillbirths and deaths in children

Valacyclovir for the prevention of cytomegalovirus infection after kidney transplantation

BMC Infectious Diseases

6.03.2025

. Background. Cytomegalovirus (CMV) infection is a frequent complication after kidney transplantation (KT) and has various effects on recipient and graft survival. Although guidelines recommend anti-viral prophylaxis with ganciclovir or valganciclovir, there is a demand for alternative regimen for CMV prevention. We investigated the effects of a 3-month valacyclovir-based prophylaxis on CMV infection and clinical outcomes in KT recipients using a nationwide cohort.

Clinical manifestations in patients with anti-IFN-γ autoantibodies syndrome and Talaromyces marneffei infection: a prospective cohort study

BMC Infectious Diseases

1.03.2025

. Abstract. . Background. Anti-interferon-γ autoantibodies syndrome (AIGAs syndrome) is characterized by disseminated infections involving various pathogens. The clinical manifestations of AIGAs syndrome with Talaromyces marneffei (TM) infection are not yet completely understood. . . . Methods.

Cytomegalovirus reactivation and acute and chronic complications in children with cerebral malaria: a prospective cohort study

Malaria Journal

19.02.2025

. Abstract. . Background. Virus co-infection or reactivation may modify the host response during cerebral malaria. Cytomegalovirus (CMV) DNAemia has been associated with increased morbidity and mortality in adults with sepsis; however, the impact of CMV DNAemia on adverse outcomes in children with cerebral malaria is unknown. . . . Methods.

Postnatal cytomegalovirus infection and its effect on hearing and neurodevelopmental outcomes among infants aged 3–10 months: A cohort study in Eastern Uganda

PLoS One Infectious Diseases

6.02.2025

… Weeks, Fred Bisso, Thorkild Tylleskär, Kathy Burgoine, Ingunn Marie Stadskleiv Engebretsen . Background Hearing impairment and neurodevelopmental disorders pose a significant global health burden in children. The link between postnatal cytomegalovirus (CMV) infection and these outcomes remains unclear. This study explored the association of postnatal CMV infection with hearing and neurodevelopmental outcomes in term infants aged 3 to 10 months.

Predictors of cytomegalovirus infection in patients with connective tissue disease treated by pulsed methylprednisolone therapy: a multicenter retrospective cohort study

BMC Infectious Diseases

1.02.2025

. Abstract. . Background. Cytomegalovirus (CMV) can cause life-threatening diseases in immunosuppressed patients. Some of the patients with connective tissue disease develop CMV infection, and approximately half of this group has been reported to have received pulsed-methylprednisolone (p-MPSL) therapy.

Taming the transplant troll: Exploring racial and ethnic disparities in cytomegalovirus infection among kidney transplant patients

PLoS One Infectious Diseases

30.01.2025

by M. Gabriela Cabanilla, Ashlee Dauenhauer, Briana St John, Deirdre Hill, Joshua Larson . Background Cytomegalovirus (CMV) infection poses a significant risk to kidney transplant recipients. This study investigated CMV disease incidence, outcomes, and management challenges in racial and ethnic minority populations following kidney transplantation.

Inherited metabolic diseases are a potent risk factor for cytomegalovirus infection in pediatric living donor liver transplantation

BMC Infectious Diseases

23.01.2025

. Abstract. . Background. Cytomegalovirus (CMV) is a major infectious complication in solid-organ transplant recipients, particularly in the context of pediatric liver transplantation. CMV serostatus is a well-established risk factor for postoperative CMV infection, with CMV seronegative recipients who receive organs from seropositive donors (D+/R−) being at the highest risk.

Active cytomegalovirus infection in mechanically ventilated patients with sepsis

BMC Infectious Diseases

19.12.2024

. Abstract. . Background. Active cytomegalovirus (CMV) infection is associated with poor prognosis in septic patients with critical illness. Patients of septic category are highly likely to benefit from prophylactic antiviral therapy. Nevertheless, the clinical characteristics for CMV reactivation are lacking among septic patients requiring mechanical ventilation.

Optimization of antiviral dosing in Herpesviridae encephalitis: a promising approach to improve outcome?

Clinical Microbiology and Infection

13.12.2024

Despite established antiviral therapy for herpes simplex (HSV), varicella zoster (VZV) and cytomegalovirus (CMV) encephalitis, outcome remains poor.

Søgning

DSI på

Nyhedsbrev